Home The Active Ingredient Matrix Alpha-galactosidase

Formulation Intelligence

Alpha-galactosidase

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Alpha-galactosidase.

A glycoside hydrolase enzyme that catalyzes the hydrolysis of terminal alpha-galactosyl moieties from glycolipids and glycoproteins, primarily utilized to mitigate gastrointestinal distress caused by the fermentation of complex carbohydrates.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

11966178

Molecular Weight

1214.2 g/mol

XLogP3 (Lipophilicity)

0.2

IUPAC Name

S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (6R)-6-[(3R,5S,7R,8S,9S,10R,13R,14S,17R)-3,7-dihydroxy-5,10,13-trimethyl-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-3-hydroxy-2-methylheptanethioate

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

  • Lactase for synergistic reduction of multi-saccharide induced flatulence
  • Invertase for comprehensive hydrolysis of raffinose-family oligosaccharides

Biological Formulation Enhancers

  • Enteric coating for protection against gastric acid denaturation
  • Calcium ions for structural stabilization of the enzyme's catalytic domain

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Alpha-galactosidase across standard consumer modalities.

💊 Standard Capsules

The hygroscopic nature of the enzyme powder requires low-moisture HPMC capsules to maintain long-term enzymatic stability and prevent clumping.

🍬 Gummy & Pectin Formats

The thermal sensitivity of the protein structure necessitates a low-heat or post-deposition cooling process to avoid total loss of enzymatic activity during pectin setting.

🔬 Thin-Film Oral Strips

The high dosage required for therapeutic efficacy (GalU) exceeds the typical 20-50mg payload capacity of thin-film polymer matrices.

For Brand Founders

Formulate with Alpha-galactosidase

Ready to launch a product featuring Alpha-galactosidase? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Alpha-galactosidase Bioavailability

Need absolute proof that your Alpha-galactosidase extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Alpha-galactosidase Degradation Testing

Is your Alpha-galactosidase payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation